亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > Asarylaldehyde 細辛醛 4460-86-0
Asarylaldehyde 細辛醛 4460-86-0
單價 10.00 / g對比
銷量 暫無
發貨 四川成都市付款后3天內
庫存 1000g起訂1g
品牌 成都云希
CAS號 4460-86-0
外觀 白色粉末
過期 長期有效
更新 2021-07-30 12:20
 
詳細信息

Asarylaldehyde 細辛醛

Products Name:Asarylaldehyde

Cat NO.: BP0275

CAS NO.:4460-86-0

Appearance: White Powder

Formula:C10H12O4
Mol Weight:196.202

Botanical Source:Acorus Tatarinowii Schott

Purity: 95%~99%

*pound Type:Phenols

Analysis Method: HPLC-DAD or/and HPLC-ELSD 

Identification Method: Mass, NMR

Packing: Brown vial or HDPE plastic bottle

Storage:-2-8℃,Cool and dry place,Keep away from strong sunlight

Production Ability:Can be supplied from milligrams to grams and please inquire for bulk scale.

Remark:In case of quality issues, please contact us within 15days after received of products.


成都云希產品:
抗皺抗衰類:阿基瑞林,乙酰基八肽-3,芋螺肽,膠原肽,棕櫚酰五肽-3,五肽-18,六肽-10,脂肽,維洛斯肽,L-肌肽,基肽3000等
美白淡斑類:四肽-30,九肽-1,亮膚素,十肽-12,寡肽-68等
促進毛發生長類:肉豆蔻酰五肽-17/睫毛肽,乙酰基四肽-3/促眉肽(Capixyl),生物素三肽-1(Procapil),銅肽等
抗敏抗炎類:棕櫚酰四肽-7,乙酰基六肽-49,棕櫚酰三肽-8等
眼部護理類:二肽-2,乙酰基四肽-5(眼絲氨肽),眼麗肽(Eyeliss)等
抗痘類:機體防御肽(Bodyfension),肉豆蔻酰六肽-23,LZ1,LL37等
屏障修復類:乙酰基七肽-4
增加/減少局部脂肪體積:乙酰六肽-38 (Adifyline);乙酰六肽-39(Silusyne);五肽-25等
以及玻色因及其他多種化妝品原料、復合肽類、寡肽類、重組蛋白類、多肽中間體、植物單體、藥物肽等。云希嚴格按照標準化生產和質量管理,優價提供各品種原料,及各類半成品(原液、凍干粉等)。

©2025 成都云希化工有限公司 版權所有   技術支持:化工網   訪問量:41309  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |